A substance being studied in the treatment of multiple myeloma and several other types of cancer. It binds to CD74, a protein on the surface of myeloma cells and certain other types of cells. It may help kill cancer cells. Milatuzumab is a type of monoclonal antibody. Also called hLL1 and IMMU-110.